FindMyKOL
Clinical trialNCT02923011RecruitingPhase 3Interventional

Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

SponsorMatthew BucknorEnrollment56Osteoid Osteoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Osteoid osteomas are painful, benign bone tumors that occur most frequently in young males between ages 10 and 20 years. The goal of the proposed study is based on the premise that MRgFUS is noninferior to CT-guided radiofrequency ablation (CTgRFA), in terms of pain reduction following treatment of osteoid osteomas, and offers possible improvements with regards to 1) post-procedural pain, 2) clinical resource utilization, 3) patient experience, and/or 4) adverse events. The data from the current study would provide clinicians important information in deciding between treatment options for ablation of osteoid osteomas.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford Medical Center

    Palo Alto, California, United States

    Pejman Ghanouni, MD, PhD
    Recruiting
  • Ucsf Imaging Center

    San Francisco, California, United States

    Matthew Bucknor, MD
    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Christin Tiegs-Heiden, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Mar 2017
Primary completion
30 Jun 2025
Completion
30 Jun 2025
Last update posted
19 Feb 2025
Registered enrollment
56
Registry id
NCT02923011

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.